The RET proto-oncogene: A challenge to our understanding of disease pathogenesis

Pediatric Surgery International

Volumn 12, Issue 1, 1997, Pages 11-18

  Kusafuka, T ^a   Puri, P ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Hirschsprung's disease; Multiple endocrine neoplasia; RET; RET proto oncogene

Indexed keywords

ARTICLE; CODON; FAMILIAL CANCER; GENE MUTATION; GENE REARRANGEMENT; GENETIC TRANSFORMATION; HIRSCHSPRUNG DISEASE; HUMAN; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; PAPILLARY CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID CARCINOMA;

EID: 8044261417     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01194794     Document Type: Article

References (99)

1. Takahashi M, Ritz J, Cooper G (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42: 581-588
2. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains Oncogene 3: 571-578
3. Takahashi M, Buma Y, Hiai H (1989) Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene 4: 805-806
4. Tahira T, Ishizaka Y, Itoh F, Sugimura T, Nagao M (1990) Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 5: 97-102
5. Ceccherini I, Bocciardi R, Luo Y, Pasini B, Hofstra R, Takahashi M, Romeo G (1993) Exon structure and flanking intronic sequences of the human RET proto-oncogene. Biochem Biophys Res Commun 196: 1288-1295
6. Kwok J, Gardner E, Warner J, Ponder B, Mulligan L (1993) Structural analysis of the human ret proto-oncogene using exon trapping. Oncogene 8: 2575-2582
7. Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, Fertitta A, Carrano AV, Nagao M (1989) Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene 4: 1519-1521
8. Schneider R (1992) The human protooncogene ret: a communicative cadherin? TIBS 17: 468-469
9. Jing S (1996) Cell 85: 1113-1124
10. Trupp M, Arenas E, Fainzilber M, Nilsson A, Sieber B, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381: 785-789
11. Durbec P, Marcos-Gutierrez C, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M (1996) GDNF signalling through the ret receptor tyrosine kinase. Nature 381: 789-793
12. Treanor J, Goodman L, de Sauvage F, Stone D, Poulson K, Beck C, Gray C, Armanini M, Pollock R, Hefti F (1996) Characterization of a multicomponent receptor for GDNF. Nature 382: 80-83
13. Lin L, Doherty D, Lile J, Bektesh S, Collins F (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132
14. Henderson C, Phillips H, Pollock R, Davies A, Lemeulle C, Armanini M, Simpson L, Moffet B, Vandlen R, Koliatsos V (1994) GDNF: a potent survival factor for motoneurons, present in peripheral nerve and muscle. Science 266: 1062-1064
15. Tomac A, Lindqvist E, Lin L, Ogren S, Young D, Hoffer B, Olson L (1995) Protection and repair of the nigrostriatal dopami-nergic system by GDNF in vivo. Nature 373: 335-339
16. Beck K, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen R, Rosethal A, Hefti F (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339-341
17. Yan Q, Matheson C, Lopez O (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373: 341-344
18. Oppenheim R, Houenou L, Johnson J, Lin L, Li L, Lo A, Newsome A, Prevette D, Wang S (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373: 344-346
19. Fusco A, Grieco M, Santoro M, Berlingieri M, Pilotti S, Pierotti M, Della P, Vecchi G (1987) A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328: 170-172
20. Grieco M, Santoro M, Berlingieri M, Melillo R, Donghi R, Bongarzone I, Pierotti M, Della Porta D, Fusco A, Vecchio G (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557-563
21. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 377-378
22. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 378-380
23. Donis-Keller H, Dou S, Chi D, Carlson K, Yoshima K, Lairmore T, Howe J, Moley J, Goodfellow P, Wella S Jr. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851-856
24. Mulligan L, Kwok J, Healey C, Elsdon M, Eng C, Gardner E, Love D, Mole S, Moore J, Papi L (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460
25. Mulligan L, Eng C, Healey C, Clayton D, Kwok J, Gardner E, Ponder M, Frilling A, Jackson C, Lehnen H (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6: 70-74
26. Hofstra R, Landsvater R, Ceccherini I, Stulp R, Stelwagen T, Luo Y, Pasini B, Hoppener J, van Amstel H, Romeo G (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375-376
27. Eng C, Smith D, Mulligan L, Nagai M, Healey C, Ponder M, Gardner E, Scheumann G, Jackson C, Tunnacliffe A ( 1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 3: 237-241
28. Carlson K, Dou S, Chi D, Scavarda N, Toshima K, Jackson C, Wells SJ, Goodfellow P, Donis-Keller H (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia 2B. Proc Natl Acad Sci U S A 91: 1579-1583
29. Schiller M, Levy R, Shawa R, Abu-Dalu K, Gorenstein A, Katz S (1990) Familial Hirschsprung's disease - a report of 22 affected siblings in four families. J Pediatr Surg 25: 322-325
30. Stannard V, Fowler C, Roginson L, Besner G, Click P, Allen J, Jewett T, Cooney D (1990) Familial Hirschsprung's disease: report of autosomal dominant and probable autosomal recessive X-linked kindreds. J Pediatr Surg 26: 591-594
31. Badner J, Sieber W, Garver K, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Genet 46: 568-580
32. Schimke R (1984) Genetic aspects of multiple endocrine neoplasia. Annu Rev Med 35: 25-31
33. Verdy M, Weber A, Roy C, Morin C, Cadotte M, Brochu P (1982) Hirschsprung's disease in a family with multiple endocrine neoplasia type 2. J Pediatr Gastroenterol Nutr 1: 603-607
34. Schimke R, Hartmann W, Prout T, Rimoin D (1968) Syndrome of bilateral pheochromocytoina, medullary thyroid carcinoma and multiple neuromas. N Engl J Med 279: 1-7
35. Chong G, Beahrs O, Sizemore G, Woolner L (1975) Medullary carcinoma of the thyroid gland. Cancer 33: 695-704
36. Farndon J, Leight G, Dilley W, Baylin S, Smallridge R, Harrison T, Wells SJ (1986) Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct entity. Br J Surg 73: 278-281
37. Pachnis V, Mankoo B, Costantini F (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005-1017
38. Avantaggiato V, Dathan N, Grieco M, Fabien N, Lazzaro D, Fusco A, Simeone A, Santoro M (1994) Developmental expression of the RET protooncogene. Cell Growth Diff 5: 305-311
39. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J (1995) Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10: 191-198
40. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor ret. Nature 367: 380-383
41. Sanches M, Silos-Santiago I, Frisen J, He B, Lira S, Barbacid M (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382: 70-73
42. Pichel J, Shen L, Sheng H, Granholm A, Drago J, Grinberg A, Lee E, Huang S, Saarma M, Hoffer B (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73-76
43. Moore M, Klein R, Farinas I, Sauer H, Armanmi M, Phillips H, Reichardt L, Ryan A, Carver-Moore K, Rosenthal A (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76-79
44. Kusafuka T, Puri P. Altered RET gene mRNA expression in Hirschsprung's disease. J Pediatr Surg: (in press)
45. Martucciello G, Favre A, Takahashi M, Jasonni V (1995) Immunohistochemical localization of RET protein in Hirschsprung's disease. J Pediatr Surg 30: 433-436
46. Tam P, Gould S, Martucciello G, Biddolph S, Takahashi M, Jasonni V (1996) Ret protein in the human fetal rectum. J Pediatr Surg 31: 568-571
47. Yntema C, Hammond W (1954) The origin of intrinsic ganglia of trunk viscera from vagal neural crest in the chick embryo. J Comp Neurol 101: 515-542
48. Le Douarin N, Teillet M (1973) The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morph 30: 31-48
49. Durbec P, Larsson-Blomberg L, Schuchardt A, Costantini F, Pachnis V (1996) Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development 122: 349-358
50. Lo L, Anderson D (1995) Postmigratory neural crest cells expressing c-RET display restriction developmental and proliferative capacities. Neuron 15: 527-539
51. Shah N, Marchionni M, Isaacs I, Stroobant P, Anderson D (1994) Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77: 349-360
52. Stemple D, Anderson D (1992) Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71: 973-985
53. Martucciello G, Bicocchi M, Dodero P, Lerone M, Silengo Cirillo M, Puliti A, Gimelli G, Romeo G, Jasoni V (1992) Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10. Pediatr Surg Int 7: 308-310
54. Luo Y, Ceccherini I, Pasini B, Matera I, Bicocchi M, Barone V, Bocciardi R, Kaariainen H, Weber D, Devoto M (1993) Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet 2: 1803-1808
55. Fewtrell M, Tam P, Thomson A, Fitchett M, Currie J, Huson S, Mulligan L (1994) Hirschsprung's disease associated with deletion of chromosome 10 (q11.2q21.2): a further link with the neurocristopathies? J Med Genet
56. Lyonnet S, Bolino A, Pelet A, Abel L, Nihoul-Fekete C, Briard M, Mok-Siu V, Kaariainen H, Martucciello G, Lerone M (1993) A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet 4: 346-350
57. Angrist M, Kauffman E, Slaugenhaupt S, Matise T, Puffenberger E, Washington S, Lipson A, Cass D, Reyna T, Weeks D (1993) A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nat Genet 4: 351-356
58. Chakravarti A (1996) Endothelin receptor-mediated signaling in Hirschsprung disease. Hum Mol Genet 5: 303-307
59. Angrist M, Bolk S, Thiel B, Puffenberger E, Hofstra R, Buys C, Cass D, Chakravarti A (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4: 821-830
60. Attie T, Pelet A, Edery P, Eng C, Mulligan L, Amiel J, Boutrand L, Beldjord C, Nihoul-Fekete C, Munnich A (1995) Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4: 1381-1386
61. Kusafuka T, Wang Y, Puri P (1996) Mutation analysis of the RET, the endothelin-B receptor and the endothelin-3 genes in sporadic patients with Hirschsprung's disease. J Pediatr Surg: (in press)
62. Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, Yanagisawa M (1994) Targeted and natural (piebaldlethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79: 1267-1276
63. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravarti A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79: 1257-1266
64. Kusafuka T, Puri P (1997) Mutations of the endothelin-B receptor and endothelin-3 genes in Hirschsprung's disease. Pediatr Surg Int: (in press)
65. Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79: 1277-1285
66. Lane P, Liu H (1984) Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered 75: 435-439
67. El-Halaby E, Coran A (1994) Hirschsprung's disease associated with Ondine's curse: report of three cases and review of the literature. J Pediatr Surg 29: 530-535
68. Barone V, Weber D, Luo Y, Brancolini V, Devoto M, Romeo G (1996) Exclusion of linkage between RET and neuronal intestinal dysplasia type B Am J Med Genet 62: 195-198
69. Bolk S, Angrist M, Schwartz S, Silvestri J, Weese-Mayer D, Chakravarti A (1996) Congenital central hypoventilation syndrome: Mutation analysis of the receptor tyrosine kinase RET. Am J Med Genet 63: 603-609
70. Pasini B, Borrello MG, Greco A, Bongarzone I, Luo Y, Mondellini P, Alberti L, Miranda C, Arighi E, Bocciardi R (1995) Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet 10: 35-40
71. Pierotii M, Santoro M, Jenkins R, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Herrmann M, Fusco A (1992) Characterization of an inversion on the long arm of chromosome 10 juxtaposing D 10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci U S A 89: 1616-1620
72. Bongarzone I, Monzini N, Borrello M, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti M (1993) Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13: 358-366
73. Sozzi G, Bongarzone I, Miozzo M, Berrello M, Blutti M, Pilotti S, Della Porta G, Pierotti M (1994) A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chromosom Cancer 9: 244-250
74. Bongarzone I, Butti M, Coronelli S, Borrello M, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti M (1994) Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinoma. Cancer Res 54: 2979-2985
75. Santoro M, Dathan N, Berlingieri M, Bongarzone I, Paulin C, Grieco M, Pierotti M, Vecchio G, Fusco A (1994) Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9: 509-516
76. Minoletti F, Butti M, Coronelli S, Miozzo M, Sozzi G, Pilotti S, Tunnacliffe A, Pierotti M, Bongarzone I (1994) The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosom Cancer 11: 51-57
77. Santoro M, Carlomagno F, Hay I, Hermann M, Grieco M, Melillo R, Pierotti M, Bongarzone I, Della Porta G, Berger N (1992) Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89: 1517-1522
78. Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli M, Paulin C (1993) Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br J Cancer 68: 460-464
79. Ito T, Seyama T, Iwamoto K, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N, Akiyama M (1993) In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53: 2940-2943
80. Ito T, Seyama T, Iwamoto K, Mizuno T, Tronko N, Komissarenko I, Cherstovoy E, Satow Y, Takeichi N, Dohi K (1994) Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet 344: 259
81. Simpson N, Kidd K, Goodfellow P, McDermid H, Myers S, Kidd J, Jackson C, Duncan A, Farrer L, Brasch K (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328: 528-530
82. Mathew C, Chin K, Easton D, Thorpe K, Carter C, Liou G, Fong S, Bridges C, Haak H, Nieuwenhuijzen Krusman A (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328: 527-528
83. Lairmore T, Howe J, Korte J, Dilley W, Aine I, Aine E, Wells S, Donis-Keller H (1991) Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. Genomics 9: 181-192
84. Carson N, Wu J, Jackson C, Kidd K, Simpson N (1990) The mutation for medullary thyroid carcinoma with parathyroid tumours (MTC with PTs) is closely linked to the centromeric region of chromosome 10. Am J Hum Genet 47: 946-951
85. Gardner E, Papi L, Easton D, Cummings T, Jackson C, Kaplan M, Love D, Mole S, Moore J, Mulligan L (1993) Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2. Hum Mol Genet 2: 241-246
86. Mole S, Mulligan L, Healey C, Ponder B, Tunnacliffe A (1993) Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2. Hum Mol Genet 2: 247-252
87. Mulligan I, Eng C, Attie T, Lyonnet S, Marsh D, Hyland V, Robinson B, Frilling A, Verellen-Dumoulin C, Safar A (1994) Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 3: 2163-2167
88. Mulligan L, Marsh D, Robinson B, Schuffenecker I, Zedenius J, Lips C, Gagel R, Takai S, Noll W, Fink M (1995) Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med 238: 343-346
89. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir G (1994) RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 3: 1939-1943
90. Eng C, Smith D, Mulligan L, Healey C, Zvelebil M, Stonehouse T, Ponder M, Jackson C, Waterfield M, Ponder B (1995) A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10: 509-513
91. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, Chabrier G, Houdent C, Murat A, Schlumberger M (1995) RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10: 2415-2419
92. Hanks S, Quinn A, Hunter T (1988) The protein kinase family: conserved features and deduced phytogeny of the catalytic domain. Science 241: 42-52
93. Eng C, Mulligan L, Smith D, Healey C, Frilling A, Raue F, Neumann H, Pfragner R, Behmel A, Lorenzo M (1995) Mutation of the RET proto-oncogene in sporadic medullary thyroid carcinoma. Genes Chromosom Cancer 12: 209-212
94. Tong Q, Li Y, Smanik P, Fithian L, Xing S, Mazzaferri E, Jhiang S (1995) Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene. Oncogene 10: 1781-1787
95. Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15: 1613-1619
96. Borrello M, Smith D, Pasini B, Bongarzone I, Greco A, Lorenzo M, Arighi E, Miranda C, Eng C, Alberti L (1995) RET activation by germline MEN 2A and MEN 2B mutations. Oncogene 11: 2419-2427
97. Santoro M, Carlomango F, Romano A, Bottaro D, Dathan N, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus M (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267: 381-383
98. Songyang Z, Carraway KI, Eck M, Harrison S, Feldman R, Mohammadi M, Schlessinger J, Hubbard S, Smith D, Eng C (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373: 536-539
99. Borst M, VanCamp J, Peacock M, Decker R (1995) Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease. Surgery 117: 386-391